Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-21-023012

Options or other derivatives

  • Director acquired 15,576 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Phillips Gary M. Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +13,534 13,534 D
Phillips Gary M. Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +1,167 1,167 D
Phillips Gary M. Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +875 875 D
Loading xslF345X03/doc4.xml…